iBond到期| 年化回報近6厘?末日iBond最後倒數 – 香港經濟日報 – 知識 – 財金 – shareandstocks.com

港府第八批iBond(04246)也是最後一個現存iBond,將於本月23日到期,由現在計算尚有兩周及不足10個交易日。該債券價格已見走強並逐漸接近原價的100元。現價買入除可賺價差外,若計及最後一期

港府第八批iBond(04246)也是最後一個現存iBond,將於本月23日到期,由現在計算尚有兩周及不足10個交易日。該債券價格已見走強並逐漸接近原價的100元。現價買入除可賺價差外,若計及最後一期
Friday’s Runners: It was the end of a wild week on Friday, and we left off in our premarket report with four possible options trading targets, all to the short side. The markets fell early and struggled in the first hour or so before recovering the lost ground later in the day. We were still able to see…
September 25, 2025September 25, 2025 On 25th September, PM Narendra Modi stated that GST reforms will continue. He mentioned that the tax burden on citizens will gradually decrease as India’s economy grows. Speaking at the Uttar Pradesh International Trade Show 2025, he highlighted the country’s…
NVIDIA stock running out of steam in the near term Paul Bradbury/OJO Images via Getty Images Performance Assessment My Q2 FY25 preview note on Nvidia Corporation (NASDAQ:NVDA) communicated a change in stance from my earlier bullish view to a more cautious “Neutral/Hold.” After earnings, Nvidia closed at $116.95; 7.9% lower than the $126.46 level where…
Indian markets ended with strong gains on Friday aided by buying action in IT and FMCG stocks. The index has moved higher after finding support at the 21-day EMA and broadly speaking, the Nifty appears to be consolidating within the range of 24,700–25,000. Commenting on the day’s action, Rupak De, Senior Technical Analyst at LKP…
Although this year has been strong for Canadian equity markets, with the benchmark S&P/TSX Composite Index gaining roughly 30% and concerns around ongoing geopolitical tensions, the potential for an artificial intelligence (AI) bubble and elevated valuations remain. As a result, investors should be cautious when deploying capital through their tax-free savings accounts (TFSAs), as market…
Calzada Limited (CZD), formerly named Metabolic Pharmaceuticals Limited (MBP) is a biotechnology company involved in the development of pharmaceutical treatments for metabolic diseases. For previous discussion of this company please see the MBP thread, which can be found here: https://www.aussiestockforums.com/forums/showthread.php?t=641 Source link